Live Cell Imaging Market Research Report – Forecast to 2027

Live Cell Imaging Market Research Report: Products (Equipment, Consumables, Software), Technology (Fluorescence Recovery After Photobleaching (FRAP), Others), Application (Drug Discovery, Cell Biology, Others), End-User- Forecast Till 2027

ID: MRFR/MED/4617-HCR | February 2021 | Region: Global | 100 pages         

Live Cell Imaging Market

The live cell imaging market will grow at 9.0% CAGR to reach value of USD 8.5 billion by 2027

Segmentation

By product Equipment Consumables Software
By technology Fluorescence recovery after photobleaching(FRAP) Total Internal Reflection Fluorescence Microscopy (TRIF) High-content analysis Fluorescence in situ hybridization
By application Drug discovery Cell biology Stem cells Development biology Others
By end-user Pharmaceutical companies Hospitals Biotechnological companies

Key Players

  • Carl Zeiss AG (Germany)
  • Leica Microsystems (Germany)
  • Olympus Corporation (Japan)
  • Sigma-Aldrich Corporation (U.S.)
  • Nikon Corporation (Japan)
  • Molecular Devices
  • LCC (U.S.)
  • PerkinElmer
  • Inc. (U.S.)
  • GE Healthcare (U.K.)
  • Becton
  • Dickinson and Company (U.S.)
  • Thermo Fisher Scientific
  • Inc. (U.S.)
  • Danaher Corporation (U.S.)
  • and BioTek Instruments (U.S.)

Drivers

  • Rising prevalence chronic diseases
  • Growing government funding in cell-based research
Speak to Analyst Request a Free Sample

Live Cell Imaging Market Overview


It is expected that the live cell imaging market will grow at 9.0% CAGR to reach value of USD 8.5 billion by 2027. Live cell imaging is a technological process done in the healthcare sector. It is a study of cells in real-time using the images obtained from the microscopes and screening system. This technique helped to observe the condition of the cells and the structure and function of the cells in real-time by having better in-depth insight into the cell. The basic application of live cell imaging includes studying the process and examination of the cells. It helps to understand the cell dynamics in genetics, neurology, microbiology, etc. The increasing cancer is a prominent factor in the market's growth. The Live Cell Imaging Market Forecast shows the market will have significant growth in the forthcoming years.


Covid-19 analysis


The Healthcare sector was not affected like the other sectors. Where there was a restriction everywhere, healthcare was open to the public. But due to the growing covid 19 cases, the medical sector focused on the virus to lessen the effect and limit the spread. There Were many types of research and development was also made. The vaccines lessen the virus effect, and the markets are now operating like before, but it will take time to gain all those losses that the industries went through in the tough times. The live-cell imaging market didn't get affected much as during the pandemic. The healthcare sector was also operating where there was a continuous process going on, and the use of live-cell imaging was also continuously happening in the healthcare industries.


Chief Factors Existing In The Market 



  • Key Drivers


Several factors are driving the market growth and making it visible worldwide. The government of many regions is continuously funding cell-based research and improving the market situation. The increasing number of cancer patients worldwide boosts the Live Cell Imaging Market Value. The growth of the high content screening process is also propelling the market. The technique can study cellular integrity enzyme activity, exocytosis and others. Pharmaceutical companies use these techniques for research and development to form new medicines that have an accelerating effect on the live cell imaging market. In addition to it, it can also be used to understand the cellular structure and dynamic processes.



  • Market Challenges


The high cost of screening and less awareness among rural people about the technique is challenging the market further. Minimum knowledge and requirement of skilled professionals are challenging the market to overcome them soon. The new entrants of the market must give importance to the challenges and try to demean them soon to have a growing place globally.



  • Market Opportunities


The increasing investment for the training and development of various reasons creates many opportunities for the market. For the development of personalized medicines, live-cell imaging is used, and this demand is expected to open up many doors for the market. The demand for the will grow tremendously in the future.



  • Market Restraints


With many advantaging factors, the market also contains many restraints. The high value for the implementation of live-cell imaging acts as a limiting factor for the market. The technology needs skilled experts who have the knowledge and can understand the process, but the lack of skilled professionals is one of the main factors for lessening the market size.


Cumulative Evaluation Of The Market


the live cell imaging market shows the impacts of several factors on the market. The impact of drivers in the market is positive; the factors make the high register growth and will also improve with the same pace. Live Cell Imaging Market Analysis shows pandemics affected the market but not severely. But the market needs to overcome the restraints and form new strategies to flip the challenges into drivers for the Live Cell Imaging Market Growth.


Market segmentation


The Live Cell Imaging Market is segmented by product, technology,end-user and application. The segments are present in the market to give growth factors to increase the visibility of the market.



  • By product


Based on the segment product, the market is classified into equipment, consumables and software. The equipment segment registered the largest Live Cell Imaging Market Share in 2020 owing to the rising use of equipment to analyze, capture and gain information regarding the cell operation. The ongoing technological advancement that leads to the development of novel microscopes pushes the market forward.



  • By technology


The technology segment is segregated into fluorescence recovery after photobleaching(FRAP). Both segments are making the market grow, and in a short period, the market will showcase growth due to the segments.



  • By application


The Live Cell Imaging Market is bifurcated into Drug discovery, cell biology and others. The cell biology segment will dominate the market in 2020 due to the research and studies performed on molecular interaction networks. This technology offers superior clarity of structural components and further pushes its adaptation in cell biology research.



  • By end-user


The market variables are academic and research institutes and pharmaceutical and biology companies based on the end-user. The pharmaceutical and biology companies will own the market in 2020. The segment held the largest growth because the investment increased in research and development activities due to the development of the new drug. The shift of focus by the companies towards the development of personalized medicines is promoting the Live Cell Imaging Market Size.


Live Cell Imaging Market Regional analysis


The live-cell imaging market is analyzed in several regions, and those prominent regions are Europe, America, Asia, the pacific middle east and Africa. North America and South America further study the American region, and North America is further divided into Canada. U.S. Europe is further segregated into western Europe and eastern Europe, and western Europe is further studied in France, Germany, Italy, Spain, the U.K and the rest of western Europe. Asia pacific live imaging market is further analyzed into China, India, Japan, Australia, Republic of Korea, and the rest of Asia pacific. America dominates the live cell imaging market due to a well-established healthcare system, rising relevance of cancer cases and newer technology addition are factors pushing the market. High capitalization and extensive research and development to improve the data functionality and imaging quality make the region grow. Europe is showcasing the growth and is in the second position in the market due to the government support, rising patients and presence of some key players. The Asia Pacific is also growing due to the increased prevalence and demand for live-cell imaging techniques. The low-cost diagnosis and treatment options are also forming new opportunities for the market.


Competitive Intensity Within The Industry 


The live-cell imaging market contains several major players. Market development is based on the strategies carried out by the market players. It is expected that the players would have a forwarding impact on the market. In recent times, the players are depicting market conditions the steps that the investors should take for the value. Several strategies, financial condition, revenue and others ways are taken into account while depicting the future of the market growth. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships that help strengthen their market positions. Those valuable market players are



  • arl Zeiss AG Germany

  • Leica Microsystems Germany

  • Olympus Corporation Japan

  • Sigma-Aldrich Corporation U.S.

  • Nikon Corporation Japan

  • Molecular Devices, LCC U.S.

  • PerkinElmer, Inc. U.S.

  • GE Healthcare U.K.

  • Becton, Dickinson and Company U.S.

  • Thermo Fisher Scientific, Inc. U.S.

  • Danaher Corporation U.S.

  • BioTek Instruments U.S.


Recent development



  • A leading life science tool company called AXIOn biosystem focused on advanced life cell assay systems and announced the acquisition of the Netherlands-based cytosmart technologies.

  • Joffrey maltha, the CEO of CytosMART, the partnership is mutually beneficial, and the market will gain growth and product innovation.


Live Cell Imaging Market Report Overview


The report depicts an extensive analysis of the live cell imaging market Trends. It also shows current and future market dynamics globally. It was also an in-depth quantitative analysis of the market and estimation in the forecast period. The analysis helps them to understand the situation. In the report, drivers, restraints, dominant factors are also studied to provide a clear and perfect report. It highlights leading factors, prominent companies, and recent developments affecting the market. The geographical analysis has also been made in the report to improve the market.


Key industrial segments


By product



  • Equipment

  • Consumables

  • Software


By technology



  • Fluorescence recovery after photobleaching(FRAP)

  • Total Internal Reflection Fluorescence Microscopy (TRIF)

  • High-content analysis

  • Fluorescence in situ hybridization

  • Others


By application



  • Drug discovery

  • Cell biology

  • Stem cells

  • Development biology

  • Others


By end-user



  • Pharmaceutical companies

  • Hospitals

  • Biotechnological companies

  • Diagnostic labrotories

  • Others



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 8.5 Billiion
  CAGR   2020-2027: ~9%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Technology, Application, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Carl Zeiss AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), and BioTek Instruments (U.S.)
  Key Market Opportunities   Adoption of high content screening techniques in drug discovery and cell biology
  Key Market Drivers

  • Increasing prevalence of chronic diseases
  • Growing government funding in cell-based research


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Lack of technical expertise and high cost of screening systems can prohibit the live cell imaging market from achieving expected growth.

    Japan has the upper hand in the Asia Pacific live cell imaging market.

    The North American live cell imaging market would get boosted by better research and development facilities, and a hike in investment plans for the market.

    The live cell imaging market would be bolstered by industries like biotechnology companies, pharmaceutical companies, diagnostic laboratories, hospitals, and others.

    The live cell imaging market would record a CAGR of 9% during the forecast period of 2020 to 2027.